Preferred Label : didanosine;
MeSH definition : A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has
been replaced by a hydrogen. This modification prevents the formation of phosphodiester
linkages which are needed for the completion of nucleic acid chains. Didanosine is
a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by
binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate,
its putative active metabolite.;
MeSH synonym : dideoxyinosine; 2',3' dideoxyinosine; 2',3'-dideoxyinosine; ddi (antiviral);
CISMeF synonym : Bristol-Myers squibb brand of didanosine; bristol myers squibb brand of didanosine; Bristol-Myers brand of didanosine; bristol myers brand of didanosine;
MeSH hyponym : videx; NSC-612049; NSC 612049; NSC612049;
MeSH CAS label : inosine, 2',3'-dideoxy-;
MeSH Related Number : 69655-05-6 (Didanosine);
Registry Number MeSH : 69655-05-6;
Wikipedia link : https://en.wikipedia.org/wiki/Didanosine;
Is substance : O;
UNII : K3GDH6OH08;
InChIKey : BXZVVICBKDXVGW-NKWVEPMBSA-N;
Origin ID : D016049;
UMLS CUI : C0012133;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has
been replaced by a hydrogen. This modification prevents the formation of phosphodiester
linkages which are needed for the completion of nucleic acid chains. Didanosine is
a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by
binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate,
its putative active metabolite.
http://www.has-sante.fr/portail/jcms/c_2561591/fr/videx
http://www.has-sante.fr/portail/jcms/c_970612/videx
2015
false
France
French
treatment outcome
human immunodeficiency virus i infection
didanosine
administration, oral
didanosine
insurance, health, reimbursement
anti-hiv agents
reverse transcriptase inhibitors
HIV-1
hiv infections
drug therapy, combination
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_644449
http://www.has-sante.fr/portail/display.jsp?id=c_644448
2008
France
French
didanosine
anti-hiv agents
hiv infections
adult
child
reverse transcriptase inhibitors
didanosine
guidelines for drug use
---